Which one of the following drugs is most likely to cause hypoglycemia when used as monotherapy in the treatment of type 2 diabetes?

Questions 144

ATI RN

ATI RN Test Bank

CNS Stimulants Drugs Pharmacology Quiz Questions

Question 1 of 5

Which one of the following drugs is most likely to cause hypoglycemia when used as monotherapy in the treatment of type 2 diabetes?

Correct Answer: B

Rationale: In the context of CNS stimulants drugs pharmacology, understanding the effects of various medications on glucose metabolism is crucial for safe and effective patient care. In the case of the question regarding which drug is most likely to cause hypoglycemia when used as monotherapy in type 2 diabetes, the correct answer is B) Glipizide. Glipizide belongs to the class of sulfonylureas, which work by stimulating insulin release from the pancreas. This mechanism of action can lead to an increased risk of hypoglycemia, especially if the patient does not have adequate food intake or experiences increased physical activity. A) Acarbose is an alpha-glucosidase inhibitor that primarily works by delaying the digestion of carbohydrates, resulting in a gradual rise in blood glucose levels. It does not typically cause hypoglycemia. C) Metformin is a biguanide that primarily decreases hepatic glucose production and increases peripheral insulin sensitivity. It does not typically cause hypoglycemia when used as monotherapy. D) Miglitol is also an alpha-glucosidase inhibitor similar to acarbose and does not stimulate insulin release. Therefore, it is not associated with a significant risk of hypoglycemia. Educationally, it is important for healthcare providers to understand the mechanisms of action of different antidiabetic medications to make informed decisions about treatment regimens and to monitor patients for potential side effects. This knowledge helps in personalizing patient care to ensure optimal outcomes while minimizing risks.

Question 2 of 5

Which of the following benzodiazepines is expected to cause the least amount of adverse effects in the elderly?

Correct Answer: D

Rationale: In the context of CNS stimulants drugs pharmacology, choosing the benzodiazepine that causes the least amount of adverse effects in the elderly is crucial due to the increased sensitivity and susceptibility of this population to drug-related complications. In this case, the correct answer is D) Oxazepam. Oxazepam is preferred in the elderly population due to its pharmacokinetic profile. It undergoes minimal hepatic metabolism, leading to fewer drug interactions and a lower risk of accumulation in the elderly who may have compromised liver function. This reduced metabolism also results in a decreased likelihood of active metabolites contributing to adverse effects. On the other hand, options A, B, and C (Chlordiazepoxide, Diazepam, and Fluazepam) are metabolized by the liver to active metabolites that can accumulate in the elderly, leading to prolonged sedation, cognitive impairment, and increased risk of falls and fractures. These benzodiazepines also have a higher potential for drug interactions due to their hepatic metabolism, posing a greater risk of adverse effects in older adults. Educationally, understanding the pharmacokinetic differences among benzodiazepines is essential for healthcare providers working with elderly patients. By selecting medications like Oxazepam with a more favorable safety profile in this population, healthcare professionals can minimize the risk of adverse effects and optimize therapeutic outcomes when managing conditions that require CNS stimulant drugs. This knowledge empowers prescribers to make informed decisions tailored to the specific needs of elderly patients, promoting safe and effective pharmacotherapy practices.

Question 3 of 5

What are the most common adverse effects of anticonvulsive drugs?

Correct Answer: D

Rationale: In the context of CNS stimulant drugs pharmacology, understanding the adverse effects of anticonvulsive drugs is crucial for healthcare professionals to provide safe and effective patient care. The correct answer, option D, "All of the above," encompasses the most common adverse effects associated with anticonvulsive drugs. Headache and dizziness (option A) are frequently reported side effects of anticonvulsive drugs. These symptoms can impact a patient's quality of life and may require management to ensure treatment compliance and efficacy. Gastrointestinal symptoms (option B) such as nausea, vomiting, or diarrhea are also commonly observed with anticonvulsive drugs. Monitoring and addressing these side effects are essential to prevent dehydration or malnutrition in patients. Alteration of cognition and mentation (option C) is another significant adverse effect of anticonvulsive drugs. Patients may experience changes in memory, concentration, or mood, which can affect their daily functioning and overall well-being. Educationally, it is important to emphasize the comprehensive assessment and monitoring of patients receiving anticonvulsive drugs to promptly identify and manage these adverse effects. Healthcare providers should educate patients about potential side effects, strategies for symptom management, and when to seek medical assistance. Additionally, understanding the adverse effect profile of anticonvulsive drugs aids in individualizing therapy and improving patient outcomes. By selecting option D as the correct answer and understanding why options A, B, and C are incorrect in the context of anticonvulsive drugs, healthcare professionals can enhance their pharmacological knowledge and clinical decision-making skills to optimize patient care.

Question 4 of 5

An overdose victim presents with an elevated heart rate, decreased blood pressure, dilated pupils, and lethargy, followed by a tonic-clonic seizure. Which is the most likely intoxicant?

Correct Answer: C

Rationale: In this scenario, the most likely intoxicant causing the symptoms described is Amitriptyline (Option C), a tricyclic antidepressant. The elevated heart rate, decreased blood pressure, dilated pupils, lethargy, and tonic-clonic seizure are all consistent with the known toxic effects of tricyclic antidepressant overdose. Amitriptyline is known to cause anticholinergic effects leading to dilated pupils, cardiovascular toxicity resulting in tachycardia and hypotension, central nervous system depression manifesting as lethargy, and can progress to seizures in severe cases. Ethyl alcohol (Option A) overdose typically presents with symptoms like confusion, slurred speech, ataxia, and respiratory depression, which do not align with the symptoms described in the question. Methanol (Option B) overdose would present with symptoms such as metabolic acidosis, visual disturbances, and neurological symptoms, rather than the cardiovascular effects and seizures seen in the case described. Oxycodone (Option D) overdose would more likely present with respiratory depression, miosis, altered mental status, and opioid toxidrome features, which differ from the symptoms presented in the scenario. Understanding the specific toxidromes associated with different drug classes is crucial in clinical practice, especially in emergency situations. Recognizing the typical presentation of drug overdoses can aid healthcare professionals in making accurate and timely treatment decisions to improve patient outcomes.

Question 5 of 5

Which of the following mood stabilizers would be most appropriate in a patient with liver disease?

Correct Answer: A

Rationale: In a patient with liver disease, the most appropriate mood stabilizer would be lithium (Option A). Lithium is primarily excreted unchanged by the kidneys, making it the safest option in patients with liver impairment as it does not undergo hepatic metabolism. This reduces the risk of drug-induced liver injury or exacerbation of existing liver disease. Valproic acid (Option B) and carbamazepine (Option C) are metabolized in the liver and can potentially worsen liver function or cause hepatotoxicity in patients with liver disease. Valproic acid, in particular, is known for its hepatotoxic effects and is contraindicated in patients with significant hepatic impairment. Choosing "None of the above" (Option D) is incorrect because lithium, as mentioned earlier, is the preferred mood stabilizer in patients with liver disease due to its renal excretion pathway. In an educational context, understanding the pharmacokinetic profiles of different mood stabilizers is crucial in selecting the most appropriate medication for patients with specific comorbidities. It highlights the importance of individualizing treatment plans based on a patient's medical history to minimize the risk of adverse effects and optimize therapeutic outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions